What the FDA labels say about taking them together
Cyclosporine and lanreotide
Lanreotide's FDA label of October 11, 2024 names cyclosporine in its drug interactions section; the cyclosporine labels PlainMeds reads (4) do not name lanreotide. The lanreotide label: “DRUG INTERACTIONS Cyclosporine: SOMATULINE DEPOT may decrease the absorption of cyclosporine.”
Check it at the source: the cyclosporine FDA label on DailyMed (effective August 10, 2026, Novartis Pharmaceuticals Corporation); the lanreotide FDA label on DailyMed (effective October 11, 2024, Ipsen Biopharmaceuticals, Inc.).
What does the cyclosporine label say about lanreotide?
Cyclosporine's label (effective August 10, 2026) and its 3 other brand-application labels do not name lanreotide in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Neoral), Novartis Pharmaceuticals Corporation, effective August 10, 2026 (SPL set 94461af3-11f1-4670-95d4-2965b9538ae3), via openFDA; the full label on DailyMed
What does the lanreotide label say about cyclosporine?
Lanreotide label, drug interactionsDRUG INTERACTIONS Cyclosporine: SOMATULINE DEPOT may decrease the absorption of cyclosporine.
Source: FDA drug label (Lanreotide Acetate, NDA215395), Cipla USA Inc., effective September 1, 2024 (SPL set 11da176a-99bc-4ada-8b3f-6bd2b37a6313), via openFDA
Source: FDA drug label (SOMATULINE DEPOT), Ipsen Biopharmaceuticals, Inc., effective October 11, 2024 (SPL set 6e4a41fd-a753-4362-87ee-8cc56ed3660d), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Cyclosporine | Lanreotide | |
|---|---|---|
| Labeled for | Organ transplant rejection, Rheumatoid arthritis | n/a |
| Boxed warning | Yes | No |
| Pharmacy cost (NADAC) | $1.04 per unit 0.05% eye emulsion | n/a |
| Shortage now | No current entry | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once